EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

First αvβ6-integrin targeted radioligand therapy of breast cancer using Lu-177-Therahexin

Michael C Kreissl, Jan Wuestemann, Elisabeth Eppard, Daniel Hescheler, Joanna Wybranska, Dennis Kupitz, Falco Reissig, Frankis G Almaguel, Johannes Notni

European Journal of Nuclear Medicine and Molecular Imaging · 2026-06 · 53 (7) · 4311-4313

DOI: 10.1007/s00259-026-07826-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 26.02.2026. Verfasst von Michael C Kreissl und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Leipziger Strasse 44, Magdeburg, 39120, Ge…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Technische Universität München.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Breast CancerPlanar scintigraphySingle-photon emission computed tomographyTheranosticsαvβ6-Integrin

Autor:innen und Institutionen

  • Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Leipziger Strasse 44, Magdeburg, 39120, Germany.
  • TRIMT GmbH, Carl-Eschebach-Str. 7, Radeberg, 01454, Germany.
  • Center for Health Disparities and Molecular Medicine, Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, 92350 , USA.
  • Cancer Center, Loma Linda University Health, Loma Linda, CA, 92354, USA.
  • TRIMT GmbH, Carl-Eschebach-Str. 7, Radeberg, 01454, Germany. tum@notni.de.
  • Institute of Pathology, School of Medicine and Health, Technical University of Munich, Trogerstr. 18, Munich, 81675, Germany. tum@notni.de.

Förderung

  • Technische Universität München

Zitieren

APA

Kreissl, M. C., Wuestemann, J., Eppard, E., Hescheler, D., Wybranska, J., Kupitz, D., Reissig, F., Almaguel, F. G., & Notni, J. (2026). First αvβ6-integrin targeted radioligand therapy of breast cancer using Lu-177-Therahexin. European Journal of Nuclear Medicine and Molecular Imaging, 53(7), 4311-4313. https://doi.org/10.1007/s00259-026-07826-1

Vancouver

Kreissl MC, Wuestemann J, Eppard E, Hescheler D, Wybranska J, Kupitz D, et al. First αvβ6-integrin targeted radioligand therapy of breast cancer using Lu-177-Therahexin. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(7):4311-4313. doi:10.1007/s00259-026-07826-1

BibTeX
@article{Kreissl2026,
  author = {Kreissl, Michael C and Wuestemann, Jan and Eppard, Elisabeth and Hescheler, Daniel and Wybranska, Joanna and Kupitz, Dennis and Reissig, Falco and Almaguel, Frankis G and Notni, Johannes},
  title = {First αvβ6-integrin targeted radioligand therapy of breast cancer using Lu-177-Therahexin},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {7},
  pages = {4311--4313},
  doi = {10.1007/s00259-026-07826-1}
}
Kostenlos starten →